Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Usana Health Sciences Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +19 vs. Q4 2025
- Shares held
- 10.3M
- +727.4K (+7.6%) vs. Q4 2025
- Total value
- $179.6M
- −$7.93M (−4.2%) vs. Q4 2025
- New holders
- 29
- 40 more added
- Sold out
- 10
- 51 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting USNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $243.0M |
| Q1 2026 | 139 | $179.6M |
| Q4 2025 | 121 | $205.9M |
| Q3 2025 | 165 | $371.3M |
| Q2 2025 | 165 | $336.2M |
| Q1 2025 | 162 | $290.0M |
| Q4 2024 | 152 | $387.0M |
| Q3 2024 | 147 | $403.3M |
| Q2 2024 | 154 | $463.0M |
| Q1 2024 | 161 | $494.0M |
| Q4 2023 | 167 | $558.1M |
| Q3 2023 | 161 | $602.0M |
| Q2 2023 | 169 | $646.8M |
| Q1 2023 | 177 | $658.3M |
| Q4 2022 | 167 | $557.0M |
| Q3 2022 | 173 | $573.2M |
| Q2 2022 | 183 | $758.6M |
| Q1 2022 | 179 | $832.3M |
| Q4 2021 | 191 | $1.08B |
| Q3 2021 | 180 | $994.1M |
| Q2 2021 | 188 | $1.14B |
| Q1 2021 | 198 | $1.12B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Usana Health Sciences Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Skopos Labs, Inc. | 38,563 | $673.7K | 0.02% | +25,245+189.6% | Added |
| Invesco Ltd. | 40,301 | $704.1K | 0.00% | +2,478+6.6% | Added |
| Citadel Advisors LLC | 41,148 | $718.9K | 0.00% | −110,268−72.8% | Reduced |
| Bank of America Corp | 43,005 | $751.3K | 0.00% | −30,884−41.8% | Reduced |
| Royce & Associates LP | 45,411 | $793.3K | 0.01% | −7,144−13.6% | Reduced |
| Arrowstreet Capital, Limited Partnership | 46,458 | $811.6K | 0.00% | +211+0.5% | Added |
| Bank of New York Mellon Corp | 52,536 | $917.8K | 0.00% | −2,044−3.7% | Reduced |
| SEI Investments Co | 59,730 | $1.04M | 0.00% | +29,691+98.8% | Added |
| Vanguard Global Advisers, LLC | 61,158 | $1.07M | 0.00% | +61,158 | New |
| Empowered Funds, LLC | 66,293 | $1.16M | 0.01% | +5,856+9.7% | Added |
| Vanguard Fiduciary Trust Co | 67,850 | $1.19M | 0.00% | +67,850 | New |
| Algert Global LLC | 68,684 | $1.20M | 0.02% | +44,062+179.0% | Added |
| Tudor Investment Corp Et Al | 70,447 | $1.23M | 0.01% | −39,239−35.8% | Reduced |
| Lazard Asset Management LLC | 72,395 | $1.26M | 0.00% | +72,395 | New |
| Ameriprise Financial Inc | 73,380 | $1.28M | 0.00% | −1,544−2.1% | Reduced |
| Goldman Sachs Group Inc | 91,149 | $1.59M | 0.00% | −1,134−1.2% | Reduced |
| Millennium Management LLC | 92,957 | $1.62M | 0.00% | −192,459−67.4% | Reduced |
| Assenagon Asset Management S.A. | 97,022 | $1.69M | 0.00% | −5,444−5.3% | Reduced |
| Northern Trust Corp | 98,367 | $1.72M | 0.00% | +522+0.5% | Added |
| Bridgeway Capital Management, LLC | 99,093 | $1.73M | 0.03% | +5,856+6.3% | Added |
| Acadian Asset Management LLC | 101,108 | $1.76M | 0.00% | +101,108 | New |
| Allianz Asset Management GmbH | 117,499 | $2.05M | 0.00% | +28,673+32.3% | Added |
| Two Sigma Investments, LP | 144,630 | $2.53M | 0.00% | +44,042+43.8% | Added |
| Morgan Stanley | 155,484 | $2.72M | 0.00% | −145,107−48.3% | Reduced |
| D. E. Shaw & Co., Inc. | 182,483 | $3.19M | 0.00% | −20,103−9.9% | Reduced |
| American Century Companies Inc | 190,952 | $3.34M | 0.00% | −19,032−9.1% | Reduced |
| Jacobs Levy Equity Management, Inc | 192,976 | $3.37M | 0.01% | −59,119−23.5% | Reduced |
| Creative Planning | 193,148 | $3.37M | 0.00% | +68,639+55.1% | Added |
| State Street Corp | 248,035 | $4.33M | 0.00% | +8,858+3.7% | Added |
| Geode Capital Management, LLC | 264,434 | $4.62M | 0.00% | +9,614+3.8% | Added |
| AQR Capital Management LLC | 296,420 | $5.18M | 0.00% | +240,218+427.4% | Added |
| Charles Schwab Investment Management Inc | 333,112 | $5.82M | 0.00% | −20,834−5.9% | Reduced |
| Vanguard Portfolio Management LLC | 338,274 | $5.91M | 0.00% | +338,274 | New |
| Vanguard Capital Management LLC | 479,043 | $8.37M | 0.00% | +479,043 | New |
| Nantahala Capital Management, LLC | 810,074 | $14.2M | 0.88% | +225,000+38.5% | Added |
| Dimensional Fund Advisors LP | 834,223 | $14.6M | 0.00% | −14,229−1.7% | Reduced |
| Renaissance Technologies LLC | 1,017,630 | $17.8M | 0.03% | −129,693−11.3% | Reduced |
| Pzena Investment Management LLC | 1,108,933 | $19.4M | 0.06% | −25,496−2.2% | Reduced |
| BlackRock, Inc. | 1,190,416 | $20.8M | 0.00% | +78,415+7.1% | Added |
| Walleye Capital LLC | 0 | $0 | 0.00% | −66,269−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −65,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,655−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −8,900−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,320−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,949−100.0% | Sold out |
| New Age Alpha Advisors, LLC | 0 | $0 | 0.00% | −1,213−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −553−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −339−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |